SECSONAR

$OTLK

Outlook Therapeutics, Inc.

NASDAQ

2 insiders bought in 30 days

Director, 10% Owner bought $5.0M

Up 604% since last report

Insider cost basis

Insiders bought — stock holding above

+92.8%vs buy

Insider buy $0.83Now $1.60

Find before everyone else

SEC filings, insider trades & earnings for OTLK — in one place.